Hasil Pencarian - Uwe Reuter
- Menampilkan 1 - 20 hasil dari 51
- Ke Halaman Berikutnya
-
1
Monoclonal CGRP- (R) antibodies for the prevention of migraine oleh Uwe Reuter
Diterbitkan 2023-03-01Dapatkan teks lengkap
Artikel -
2
-
3
Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination oleh Bianca Raffaelli, Valeria Mussetto, Heike Israel, Lars Neeb, Uwe Reuter
Diterbitkan 2019-06-01Dapatkan teks lengkap
Artikel -
4
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study oleh Marc Ehrlich, Christian Hentschke, Christian Sieder, Monika Maier-Peuschel, Uwe Reuter
Diterbitkan 2022-11-01Dapatkan teks lengkap
Artikel -
5
Crack propagation modeling of strengthening reinforced concrete deep beams with CFRP plates oleh Shahriar Shahbazpanahi, Hogr Karim, Wrya Abdullah, Uwe Reuter, Amir H Mosavi
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
6
-
7
The potential of lasmiditan in migraine oleh Jasper Mecklenburg, Bianca Raffaelli, Lars Neeb, Margarita Sanchez del Rio, Uwe Reuter
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
8
-
9
Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study oleh Lucas Hendrik Overeem, Lucas Hendrik Overeem, Kristin Sophie Lange, Mira Pauline Fitzek, Anke Siebert, Maureen Steinicke, Paul Triller, Ja Bin Hong, Uwe Reuter, Uwe Reuter, Bianca Raffaelli, Bianca Raffaelli
Diterbitkan 2023-03-01Dapatkan teks lengkap
Artikel -
10
-
11
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention oleh Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
12
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention oleh Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Diterbitkan 2019-05-01Dapatkan teks lengkap
Artikel -
13
-
14
-
15
-
16
-
17
Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM) oleh Ana Sofia Oliveira Gonçalves, Inga Laumeier, Maxi Dana Hofacker, Bianca Raffaelli, Bianca Raffaelli, Philipp Burow, Markus A. Dahlem, Simon Heintz, Tim Patrick Jürgens, Steffen Naegel, Florian Rimmele, Simon Scholler, Tobias Kurth, Uwe Reuter, Uwe Reuter, Lars Neeb
Diterbitkan 2022-06-01Dapatkan teks lengkap
Artikel -
18
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies oleh Maria Terhart, Jasper Mecklenburg, Lars Neeb, Lucas Hendrik Overeem, Anke Siebert, Maureen Steinicke, Bianca Raffaelli, Uwe Reuter
Diterbitkan 2021-12-01Dapatkan teks lengkap
Artikel -
19
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience oleh Bianca Raffaelli, Maria Terhart, Jasper Mecklenburg, Lars Neeb, Lucas Hendrik Overeem, Anke Siebert, Maureen Steinicke, Uwe Reuter
Diterbitkan 2022-03-01Dapatkan teks lengkap
Artikel -
20
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study oleh Bianca Raffaelli, Bianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, Lucas Hendrik Overeem, Lars Neeb, Astrid Gendolla, Uwe Reuter
Diterbitkan 2020-05-01Dapatkan teks lengkap
Artikel